HARTFORD, Conn., Aug. 27, 2024 /PRNewswire/ -- Aetna®, a CVS Health® Company (NYSE: CVS), now offers intrauterine insemination (IUI) as a medical benefit for eligible plans. Members may access this benefit as a test of fertility and, in some cases, to increase the chances of pregnancy. Aetna's landmark policy change increases access to family-building possibilities, regardless of sexual orientation or partner status.
As the first major insurer to update this coverage policy nationally, Aetna is proud to better represent the needs of the communities we serve.
"Expanding IUI coverage is yet another demonstration of Aetna's commitment to women's health across all communities, including LGBTQ+ and unpartnered people," said Cathy Moffitt, MD, Senior Vice President and Aetna Chief Medical Officer, CVS Health. "This industry-leading policy change is a stake in the ground, reflecting Aetna's support of all who need to use this benefit as a preliminary step in building their family."
Aetna's Approach to Clinical Policy
Aetna's team of clinical experts update and assess clinical policies on an ongoing basis to ensure they reflect the latest understandings and guidelines. Across the industry, coverage of IUI services typically has applied to individuals who 1) purchased separate infertility benefit coverage and 2) could demonstrate an infertility diagnosis.
Aetna's updated coverage policy begins nationwide on September 1, 2024 for many plans and will be effective on a rolling basis for most plans on renewal. Aetna plan sponsors do not need to make changes, as this is a policy change for eligible medical plans. As a standard process, self-funded plan sponsors may modify their coverage of any benefit, including infertility. For more information, plan sponsors should reach out to their account managers.
Aetna remains committed to facilitating transparency and open communication with members, providers and customers by continuing to make our clinical policies public.
Commitment to Women and Equity
Many women in different communities will benefit from this change. "We know firsthand the barriers people face in accessing needed medical care to start or grow their families," said Chief Clinical Officer, Kate Steinle, of a nationwide health care provider for the LGBTQ+ community, FOLX. "As an in-network provider focused on the LGBTQ+ community, we applaud Aetna's efforts to reduce out-of-pocket costs, so that more people can have the families they dream of – and deserve."
CVS Health has a long history of supporting and advancing women's health and equity, and we remain focused on meeting their unique needs. This includes providing access to safe, legal and evidence-based reproductive health services, information and FDA-approved products.
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
About Aetna
Aetna, a CVS Health business, serves an estimated 36 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit Aetna.com (e.g., clinical diagnoses, eligibility criteria, participation in a disease state management program).
Media Contact
Alex Kepnes
703-575-8900
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$55.81 |
Daily Change: | -0.58 -1.03 |
Daily Volume: | 8,904,785 |
Market Cap: | US$70.320B |
October 16, 2024 September 12, 2024 August 01, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB